Related Experiment Videos

Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma

R Polosa1, W H Ng, N Crimi

  • 1Istituto Malattie Apparato Respiratorio, Università di Catania, Italy.

Insights

Adenosine monophosphate (AMP) triggers asthma symptoms by causing airway mast cells to release inflammatory mediators. This study found AMP induced significant increases in PGD2, histamine, and tryptase, confirming mast cell involvement in adenosine-induced bronchoconstriction.

Area of Science:

  • Pulmonary Medicine
  • Allergy and Immunology
  • Respiratory Physiology

Background:

  • Airway mast cells are implicated in bronchoconstriction.
  • Adenosine monophosphate (AMP) can induce airway narrowing.

Purpose of the Study:

  • To investigate the role of mast cell mediators in adenosine-induced bronchoconstriction.
  • To examine inflammatory mediator release and airway permeability following AMP challenge in asthmatic subjects.

Main Methods:

  • Bronchoalveolar lavage fluid was collected after endobronchial instillation of AMP in asthmatic subjects.
  • Lavage fluid was analyzed for prostaglandin D2 (PGD2), histamine, tryptase, and albumin levels.
  • Airway caliber changes were assessed following AMP challenge.

Main Results:

  • AMP challenge led to a significant reduction in airway caliber.
  • Concentrations of PGD2, histamine, and tryptase in lavage fluid significantly increased post-AMP challenge.
  • A significant rise in albumin levels indicated increased airway permeability.

Conclusions:

  • Adenosine-induced bronchoconstriction is mediated by the acute release of mast cell mediators.
  • PGD2, histamine, and tryptase are key mediators involved in AMP-induced airway responses in asthma.

Related Concept Videos